文献速递神经技术与安全MR

在多参数MRI影像组学特征用于脑肿瘤诊断中实现成像与计算可重复性:体模与临床验证

Achieving imaging and computational reproducibility on multiparametric MRI radiomics features in brain tumor diagnosis: phantom and clinical validation.
PubMed 文献 · Eur Radiol · 2023-09-04

研究以三种3-T MRI扫描仪采集标准化体模的T1WI、T2WI和DWI,用两种计算算法提取影像组学特征,以一致性相关系数大于0.9筛选可重复特征,并用随机森林分类器在临床队列(n=50)中验证其区分胶质母细胞瘤与原发性中枢神经系统淋巴瘤的价值。T2WI可重复特征多于DWI和T1WI,基于可重复特征的模型在训练集和验证集AUC均高于非可重复特征。

要点

  • T2WI来源的影像组学特征可重复性高于DWI和T1WI。
  • 可重复特征构建的模型在验证集区分胶质母细胞瘤与PCNSL的AUC为0.957,高于非可重复特征的0.869。

核心结论

  • 跨多次扫描、多台扫描仪和多种计算算法具有高可重复性的影像组学特征被识别,其在区分胶质母细胞瘤与PCNSL时诊断性能高于非可重复特征。

研究设计与样本

  • 采用标准化体模在三种3-T MRI扫描仪上采集T1WI、T2WI和DWI,用两种计算算法提取影像组学特征;以一致性相关系数大于0.9筛选可重复特征,用随机森林分类器训练(可重复特征n=117)并在临床队列(n=50)中验证。

诊断标准与关键数值

  • 可重复特征定义为跨多次扫描、多台扫描仪和多种计算算法的一致性相关系数大于0.9;T2WI可重复特征41个、DWI 6个、T1WI 2个;T2WI特征重复性65-94%,DWI 38-48%,T1WI 2-92%。

临床应用与阅片要点

  • 作者指出识别出多机可重复的影像组学特征,并显示其在区分胶质母细胞瘤与PCNSL时具有更高的影像组学诊断性能,为神经肿瘤学进一步研究设计和临床应用开辟道路。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The Image Biomarker Standardization Initiative has helped improve the computational reproducibility of MRI radiomics features. Nonetheless, the MRI sequences and features with high imaging reproducibility are yet to be established. To determine reproducible multiparametric MRI radiomics features across test-retest, multi-scanner, and computational reproducibility comparisons, and to evaluate their clinical value in brain tumor diagnosis.

METHODS: To assess reproducibility, T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and diffusion-weighted imaging (DWI) were acquired from three 3-T MRI scanners using standardized phantom, and radiomics features were extracted using two computational algorithms. Reproducible radiomics features were selected when the concordance correlation coefficient value above 0.9 across multiple sessions, scanners, and computational algorithms. Random forest classifiers were trained with reproducible features (n = 117) and validated in a clinical cohort (n = 50) to evaluate whether features with high reproducibility improved the differentiation of glioblastoma from primary central nervous system lymphomas (PCNSLs).

RESULTS: Radiomics features from T2WI demonstrated higher repeatability (65-94%) than those from DWI (38-48%) or T1WI (2-92%). Across test-retest, multi-scanner, and computational comparisons, T2WI provided 41 reproducible features, DWI provided six, and T1WI provided two. The performance of the classification model with reproducible features was higher than that using non-reproducible features in both training set (AUC, 0.916 vs. 0.877) and validation set (AUC, 0.957 vs. 0.869).

CONCLUSION: Radiomics features with high reproducibility across multiple sessions, scanners, and computational algorithms were identified, and they showed higher diagnostic performance than non-reproducible radiomics features in the differentiation of glioblastoma from PCNSL.

CLINICAL RELEVANCE STATEMENT: By identifying the radiomics features showing higher multi-machine reproducibility, our results also demonstrated higher radiomics diagnostic performance in the differentiation of glioblastoma from PCNSL, paving the way for further research designs and clinical application in neuro-oncology.

KEY POINTS: • Highly reproducible radiomics features across multiple sessions, scanners, and computational algorithms were identified using phantom and applied to clinical diagnosis. • Radiomics features from T2-weighted imaging were more reproducible than those from T1-weighted and diffusion-weighted imaging. • Radiomics features with good reproducibility had better diagnostic performance for brain tumors than features with poor reproducibility.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Cheong EN, Park JE, Park SY, et al. Achieving imaging and computational reproducibility on multiparametric MRI radiomics features in brain tumor diagnosis: phantom and clinical validation. Eur Radiol. 2023. PMID: 37665391. doi:10.1007/s00330-023-10164-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。